Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET

Maria A. Pantaleo, Eyal Mishani, Cristina Nanni, Lorena Landuzzi, Stefano Boschi, Giordano Nicoletti, Samar Dissoki, Paola Paterini, Pier Poalo Piccaluga, Filippo Lodi, Pier Luigi Lollini, Stefano Fanti, Guido Biasco

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: The in vivo evaluation of three modified polyethylene glycol (PEG)-anilinoquinazoline derivatives labeled with 124I, 18F, and 11C as potential positron emission tomography (PET) bioprobes for visualizing epidermal growth factor receptor (EGFR) in cancer using small animal PET. Procedures: Xenograft mice with the human glioblastoma cell lines U138MG (lacking EGFR expression) and U87MG.wtEGFR (transfected with an overexpressing human wild-type EGFR gene) were used. Static and dynamic PET imaging was conducted for all three PEGylated compounds. Tumor necrosis, microvessel density, and EGFR levels were evaluated by histopathology and enzyme-linked immunosorbent assay. Results: Nineteen animal models were generated (two U138MG, three U87MG, 14 with both U138MG and U87MG bilateral masses). In static images, a slight increase in tracer uptake was observed in tumors, but in general, there was no retention of tracer uptake over time and no difference in uptake between U138MG and U87MG masses. In addition, no significant uptake was demonstrated in dynamic scans of the 18F-PEG tracer. No necrosis was present except in four animals. MVD was 9.6 and 48 microvessels/×400 field in the U138GM and U87GM masses, respectively (p∈=∈0.00008). Similarly, the microvessel grades were generally higher in the U87GM group (p∈=∈0.002). Total EGFR amount was higher in U87MG than U138MG masses (p∈=∈0.001), but the ratio of activated (pY1068) to total EGFR did not differ (p∈=∈0.95). Conclusions: PEGylated tracers labeled with 11C, 124I, and 18F showed no significant difference in uptake between U138MG and U87MG glioblastoma xenograft mice. The tracer binding with EGFR could be influenced by activation of the tyrosine kinase portion of the receptor which was similar in U138MG and U87MG. Despite these results, these tracers should be investigated in animal models with mutant EGFR genes to determine whether aberrant receptor function plays a role in tumor uptake.

Original languageEnglish
Pages (from-to)616-625
Number of pages10
JournalMolecular Imaging and Biology
Volume12
Issue number6
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Epidermal Growth Factor Receptor
Positron-Emission Tomography
Microvessels
erbB-1 Genes
Neoplasms
Glioblastoma
Heterografts
Necrosis
Animal Models
Receptor Protein-Tyrosine Kinases
Biosensing Techniques
Enzyme-Linked Immunosorbent Assay
Cell Line

Keywords

  • Epidermal growth factor receptor (EGFR)
  • Small animal PET
  • Tyrosine kinase (TK) inhibitors

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET. / Pantaleo, Maria A.; Mishani, Eyal; Nanni, Cristina; Landuzzi, Lorena; Boschi, Stefano; Nicoletti, Giordano; Dissoki, Samar; Paterini, Paola; Piccaluga, Pier Poalo; Lodi, Filippo; Lollini, Pier Luigi; Fanti, Stefano; Biasco, Guido.

In: Molecular Imaging and Biology, Vol. 12, No. 6, 12.2010, p. 616-625.

Research output: Contribution to journalArticle

Pantaleo, MA, Mishani, E, Nanni, C, Landuzzi, L, Boschi, S, Nicoletti, G, Dissoki, S, Paterini, P, Piccaluga, PP, Lodi, F, Lollini, PL, Fanti, S & Biasco, G 2010, 'Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET', Molecular Imaging and Biology, vol. 12, no. 6, pp. 616-625. https://doi.org/10.1007/s11307-010-0315-z
Pantaleo, Maria A. ; Mishani, Eyal ; Nanni, Cristina ; Landuzzi, Lorena ; Boschi, Stefano ; Nicoletti, Giordano ; Dissoki, Samar ; Paterini, Paola ; Piccaluga, Pier Poalo ; Lodi, Filippo ; Lollini, Pier Luigi ; Fanti, Stefano ; Biasco, Guido. / Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET. In: Molecular Imaging and Biology. 2010 ; Vol. 12, No. 6. pp. 616-625.
@article{8ab85fed70524872809a0677a48b5733,
title = "Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET",
abstract = "Purpose: The in vivo evaluation of three modified polyethylene glycol (PEG)-anilinoquinazoline derivatives labeled with 124I, 18F, and 11C as potential positron emission tomography (PET) bioprobes for visualizing epidermal growth factor receptor (EGFR) in cancer using small animal PET. Procedures: Xenograft mice with the human glioblastoma cell lines U138MG (lacking EGFR expression) and U87MG.wtEGFR (transfected with an overexpressing human wild-type EGFR gene) were used. Static and dynamic PET imaging was conducted for all three PEGylated compounds. Tumor necrosis, microvessel density, and EGFR levels were evaluated by histopathology and enzyme-linked immunosorbent assay. Results: Nineteen animal models were generated (two U138MG, three U87MG, 14 with both U138MG and U87MG bilateral masses). In static images, a slight increase in tracer uptake was observed in tumors, but in general, there was no retention of tracer uptake over time and no difference in uptake between U138MG and U87MG masses. In addition, no significant uptake was demonstrated in dynamic scans of the 18F-PEG tracer. No necrosis was present except in four animals. MVD was 9.6 and 48 microvessels/×400 field in the U138GM and U87GM masses, respectively (p∈=∈0.00008). Similarly, the microvessel grades were generally higher in the U87GM group (p∈=∈0.002). Total EGFR amount was higher in U87MG than U138MG masses (p∈=∈0.001), but the ratio of activated (pY1068) to total EGFR did not differ (p∈=∈0.95). Conclusions: PEGylated tracers labeled with 11C, 124I, and 18F showed no significant difference in uptake between U138MG and U87MG glioblastoma xenograft mice. The tracer binding with EGFR could be influenced by activation of the tyrosine kinase portion of the receptor which was similar in U138MG and U87MG. Despite these results, these tracers should be investigated in animal models with mutant EGFR genes to determine whether aberrant receptor function plays a role in tumor uptake.",
keywords = "Epidermal growth factor receptor (EGFR), Small animal PET, Tyrosine kinase (TK) inhibitors",
author = "Pantaleo, {Maria A.} and Eyal Mishani and Cristina Nanni and Lorena Landuzzi and Stefano Boschi and Giordano Nicoletti and Samar Dissoki and Paola Paterini and Piccaluga, {Pier Poalo} and Filippo Lodi and Lollini, {Pier Luigi} and Stefano Fanti and Guido Biasco",
year = "2010",
month = "12",
doi = "10.1007/s11307-010-0315-z",
language = "English",
volume = "12",
pages = "616--625",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET

AU - Pantaleo, Maria A.

AU - Mishani, Eyal

AU - Nanni, Cristina

AU - Landuzzi, Lorena

AU - Boschi, Stefano

AU - Nicoletti, Giordano

AU - Dissoki, Samar

AU - Paterini, Paola

AU - Piccaluga, Pier Poalo

AU - Lodi, Filippo

AU - Lollini, Pier Luigi

AU - Fanti, Stefano

AU - Biasco, Guido

PY - 2010/12

Y1 - 2010/12

N2 - Purpose: The in vivo evaluation of three modified polyethylene glycol (PEG)-anilinoquinazoline derivatives labeled with 124I, 18F, and 11C as potential positron emission tomography (PET) bioprobes for visualizing epidermal growth factor receptor (EGFR) in cancer using small animal PET. Procedures: Xenograft mice with the human glioblastoma cell lines U138MG (lacking EGFR expression) and U87MG.wtEGFR (transfected with an overexpressing human wild-type EGFR gene) were used. Static and dynamic PET imaging was conducted for all three PEGylated compounds. Tumor necrosis, microvessel density, and EGFR levels were evaluated by histopathology and enzyme-linked immunosorbent assay. Results: Nineteen animal models were generated (two U138MG, three U87MG, 14 with both U138MG and U87MG bilateral masses). In static images, a slight increase in tracer uptake was observed in tumors, but in general, there was no retention of tracer uptake over time and no difference in uptake between U138MG and U87MG masses. In addition, no significant uptake was demonstrated in dynamic scans of the 18F-PEG tracer. No necrosis was present except in four animals. MVD was 9.6 and 48 microvessels/×400 field in the U138GM and U87GM masses, respectively (p∈=∈0.00008). Similarly, the microvessel grades were generally higher in the U87GM group (p∈=∈0.002). Total EGFR amount was higher in U87MG than U138MG masses (p∈=∈0.001), but the ratio of activated (pY1068) to total EGFR did not differ (p∈=∈0.95). Conclusions: PEGylated tracers labeled with 11C, 124I, and 18F showed no significant difference in uptake between U138MG and U87MG glioblastoma xenograft mice. The tracer binding with EGFR could be influenced by activation of the tyrosine kinase portion of the receptor which was similar in U138MG and U87MG. Despite these results, these tracers should be investigated in animal models with mutant EGFR genes to determine whether aberrant receptor function plays a role in tumor uptake.

AB - Purpose: The in vivo evaluation of three modified polyethylene glycol (PEG)-anilinoquinazoline derivatives labeled with 124I, 18F, and 11C as potential positron emission tomography (PET) bioprobes for visualizing epidermal growth factor receptor (EGFR) in cancer using small animal PET. Procedures: Xenograft mice with the human glioblastoma cell lines U138MG (lacking EGFR expression) and U87MG.wtEGFR (transfected with an overexpressing human wild-type EGFR gene) were used. Static and dynamic PET imaging was conducted for all three PEGylated compounds. Tumor necrosis, microvessel density, and EGFR levels were evaluated by histopathology and enzyme-linked immunosorbent assay. Results: Nineteen animal models were generated (two U138MG, three U87MG, 14 with both U138MG and U87MG bilateral masses). In static images, a slight increase in tracer uptake was observed in tumors, but in general, there was no retention of tracer uptake over time and no difference in uptake between U138MG and U87MG masses. In addition, no significant uptake was demonstrated in dynamic scans of the 18F-PEG tracer. No necrosis was present except in four animals. MVD was 9.6 and 48 microvessels/×400 field in the U138GM and U87GM masses, respectively (p∈=∈0.00008). Similarly, the microvessel grades were generally higher in the U87GM group (p∈=∈0.002). Total EGFR amount was higher in U87MG than U138MG masses (p∈=∈0.001), but the ratio of activated (pY1068) to total EGFR did not differ (p∈=∈0.95). Conclusions: PEGylated tracers labeled with 11C, 124I, and 18F showed no significant difference in uptake between U138MG and U87MG glioblastoma xenograft mice. The tracer binding with EGFR could be influenced by activation of the tyrosine kinase portion of the receptor which was similar in U138MG and U87MG. Despite these results, these tracers should be investigated in animal models with mutant EGFR genes to determine whether aberrant receptor function plays a role in tumor uptake.

KW - Epidermal growth factor receptor (EGFR)

KW - Small animal PET

KW - Tyrosine kinase (TK) inhibitors

UR - http://www.scopus.com/inward/record.url?scp=78650516740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650516740&partnerID=8YFLogxK

U2 - 10.1007/s11307-010-0315-z

DO - 10.1007/s11307-010-0315-z

M3 - Article

C2 - 20379787

AN - SCOPUS:78650516740

VL - 12

SP - 616

EP - 625

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 6

ER -